Investing.com - Gilead (NASDAQ:GILD) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Gilead announced earnings per share of $2.08 on revenue of $6.42B. Analysts polled by Investing.com anticipated EPS of $2.06 on revenue of $6.72B.
Gilead shares are down 10% from the beginning of the year and are trading at $63.11 , down-from-52-week-high.They are under-performing the S&P 500 which is up 12.13% from the start of the year.
Gilead shares lost 1.10% in after-hours trade the report.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Abbott Labs had beat expectations on Tuesday, April 20, 2021 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar